Both in Pharmaceuticals
Ardelyx vs ArriVent BioPharma
Over the past year ARDX returned −36.3% and AVBP returned −18.4%; their daily moves had a correlation of 0.18.
ARDX −36.3% AVBP −18.4%Growth of $1, one year, split-adjusted
| Metric | ARDX | AVBP |
|---|---|---|
| Price | $3.27 | $16.79 |
| Market cap | $844.3M | $827.9M |
| Today | +2.51% | +3.64% |
| 1 month | −3.5% | −39.3% |
| 6 months | −47.9% | −43.3% |
| Year to date | −43.9% | −16.6% |
| 1 year | −34.7% | −16.1% |
| Revenue growth (YoY) | +23.8% | — |
| Gross margin | 95.2% | — |
| Net margin | −13.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | — |
| Net cash | $30.0M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 48.8% | 137.8% |
| Short % of float | 11.4% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).